PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes.
Saved in:
| Title: | PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes. |
|---|---|
| Authors: | Qin, Ya-Zhen (AUTHOR), Zhu, Hong-Hu (AUTHOR), Liu, Yan-Rong1 (AUTHOR), Wang, Ya-Zhe1 (AUTHOR), Shi, Hong-Xia1 (AUTHOR), Lai, Yue-Yun1 (AUTHOR), Xu, Lan-Ping1 (AUTHOR), Liu, Dai-Hong1 (AUTHOR), Jiang, Qian1 (AUTHOR), Li, Ling-Di1 (AUTHOR), Jiang, Bin1 (AUTHOR), Liu, Kai-Yan1 (AUTHOR), Huang, Xiao-Jun1 (AUTHOR) huangxiaojun@bjmu.edu.cn |
| Source: | Leukemia & Lymphoma. Jul2013, Vol. 54 Issue 7, p1442-1449. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
